Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

20 Dec 2017

Abstract excerpt

= .02), allogeneic HSCT use remained low and largely restricted to pediatric practice. Autologous HSCT has evolved into a treatment modality to be considered alongside other modern therapies in severe AD. Center experience, accreditation, interspecialty networking, and national socioeconomic factors are relevant for health service delivery of HSCT in AD.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Bullous Skin Diseases
Share to Chronic Lymphocytic Leukemia Research
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29296926
DOI: 10.1182/bloodadvances.2017010041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesPMID 29296926Read ↗

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsSemantic proximity Read ↗

Advances in hematopoietic stem cell transplantation for autoimmune diseasesSemantic proximity Read ↗

Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsSemantic proximity Read ↗

Autoimmune Complications after Hematopoietic Stem Cell Transplantation in Children with Nonmalignant DisordersSemantic proximity Read ↗

Allogeneic HSCT in Adolescents and Young Adults With Primary ImmunodeficienciesSemantic proximity Read ↗

Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcomeSemantic proximity Read ↗

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationSemantic proximity Read ↗

Estimating prevalence of immunocompromising conditions in Canada in 2022 using an administrative hospital databaseSemantic proximity Read ↗

Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?Semantic proximity Read ↗

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I)Semantic proximity Read ↗

Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in KoreaSemantic proximity Read ↗

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.